Vaccines, Repurposed Drugs and Alternative Biomedicines for the Management and Prevention of COVID-19
The Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) popularly called as COVID-19, is a pandemic having affected >200 countries. Globally, quarantine measures have been implemented to slow down the spread of the virus. Yet, the available vaccines and drugs for treating COVID-19 are...
Guardado en:
Autores principales: | Jeyalakshmi Kandhavelu, Ramesh Veeriah, Kumar Subramanian, Priyatharsini Rajendran, Olli Yli-Harja, Meenakshisundaram Kandhavelu, Akshaya Murugesan |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
JCDR Research and Publications Private Limited
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/10663d238e3244db980da7537e9f2250 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The Barriers, Challenges, and Strategies of COVID-19 (SARS-CoV-2) Vaccine Acceptance: A Concurrent Mixed-Method Study in Tehran City, Iran
por: Hamid Reza Khankeh, et al.
Publicado: (2021) -
Inmunogenicidad de una vacuna recombinante anti hepatitis B en personal de salud
por: GARCÍA C.,PATRICIA, et al.
Publicado: (2002) -
Evaluacion de la capacidad inmunogénica de la vacuna antirrábica tipo Fuenzalida- Palacios (CRL) y de la vacuna antirrábica de cultivo celular (Verorab®) en personas con tratamiento preexposición
por: Favi C,Myriam, et al.
Publicado: (2004) -
Counting on COVID-19 Vaccine: Insights into the Current Strategies, Progress and Future Challenges
por: Ramesh Kandimalla, et al.
Publicado: (2021) -
Development Trends and Suggestions of Nucleic Acid Vaccines
por: Li Aihua, et al.
Publicado: (2021)